In T2DM patients with common multifactorial obesity, exogenous leptin administration does not seem to improve insulin sensitivity, possibly due to the resistance to leptin action [23–25], in a paradigm somehow concordant with what we have found in our observational study. Here, INS is linked to obesity disorder.